Suppr超能文献

印度阿育吠陀药典,发展与展望。

The Ayurvedic Pharmacopoeia of India, development and perspectives.

机构信息

Department of Dravyaguna, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.

Department of Pharmaceutics, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India.

出版信息

J Ethnopharmacol. 2017 Feb 2;197:32-38. doi: 10.1016/j.jep.2016.07.030. Epub 2016 Jul 9.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

The Ayurvedic Pharmacopoeia of India (API) is a unique book of standards describing the quality, purity and strength of selected drugs that are manufactured, distributed, and sold by the licensed manufacturers in pan India. It is developed in two parts; the part one comprises of mono-monographs of medicinal substances of natural origin and part two includes selected compound formulations sourced from the schedule - I books under the Drugs and Cosmetics Act, 1940 comprising of popular Ayurvedic classics of different period of times. The first part of the Ayurvedic Formulary of India was published in 1978 and thereafter, the Ayurvedic Pharmacopoeia of India (mono-monograph) Part-I, Vol. I was published in the year 1989 and subsequently, the other volumes were published with their legalized status under Drugs and Cosmetics Act, 1940.

AIM OF THE STUDY

The study was aimed to bring out the existing knowledge on the Ayurvedic pharmacopoeia with its chronological development reviewed from the ancient Vedic Compendia with its continuum in Ayurvedic classics of different period of time till recent past.

MATERIALS AND METHODS

A literary search based on the ancient origin of Ayurveda was carried out. The drug making from the natural resources and utility of the knowledge exist in classical Ayurvedic works of different period of time till composition of the Ayurvedic Pharmacopoeia of India and its importance as official documents of Govt. of India for Standards of Ayurvedic Drugs and its perspectives have been discussed.

RESULTS

The present paper reviews on the systemic development and different aspects of drug-making (Pharmacopoeia) with evidence lying in the 5000 years old work of India. During the systematic review of the various works of different period of times (ancient, medieval and modern), it was found that the Ayurvedic Pharmacopoeia of India has its development during 20th Century as an official document of Govt. of India comprising of single drugs monograph and compound formulations.

CONCLUSION

In India, the development of the Indian Pharmacopoeia started in 20th Century on the recommendation of the Col. R.N. Chopra Committee and in 1978 the first part of the Ayurvedic formulary of India was published. Subsequently, the amendment in the drugs and cosmetics Act 1940 was brought in 1964 for regulation of the drugs in Indian Systems of Medicine (Ayurveda, Unani and Siddha). Later on the Ayurvedic Pharmacopoeia of India (Mono-Monograph) Part-I, Volume I, was published in the year 1989 and the other volumes were published subsequently in different years.

摘要

民族药理学相关性

印度的《阿育吠陀药典》(API)是一本独特的标准书籍,描述了在全印度范围内制造、分销和销售的选定药物的质量、纯度和强度。它分为两部分;第一部分包括天然药物物质的单篇专论,第二部分包括选自 1940 年《药品和化妆品法》附表-I 书籍的选定复方制剂,其中包括不同时期的流行阿育吠陀经典。印度阿育吠陀配方的第一部分于 1978 年出版,此后,印度阿育吠陀药典(单篇专论)第一部分,第一卷于 1989 年出版,随后,其他卷在 1940 年《药品和化妆品法》的规定下出版。

研究目的

本研究旨在从古代吠陀文献出发,回顾阿育吠陀药理学的现有知识,并将其与不同时期的阿育吠陀经典中的连续性进行综述,直至最近。

材料和方法

根据阿育吠陀的古代起源进行文献搜索。从不同时期的经典阿育吠陀著作中的自然资源中制作药物,并利用其中的知识,并讨论了印度阿育吠陀药典的组成及其作为印度政府官方文件对阿育吠陀药物标准的重要性及其观点。

结果

本文综述了药物制作(药典)的系统发展和不同方面,并在有着 5000 年历史的印度文献中找到了证据。在对不同时期(古代、中世纪和现代)的各种著作进行系统回顾时,发现印度阿育吠陀药典的发展始于 20 世纪,作为印度政府的官方文件,包括单药专论和复方制剂。

结论

在印度,印度药典的发展始于 20 世纪,是在 R.N. Chopra 上校委员会的建议下开始的,1978 年出版了第一部分《印度阿育吠陀配方》。此后,1964 年对 1940 年《药品和化妆品法》进行了修订,以规范印度医学体系(阿育吠陀、尤纳尼和悉达)中的药物。后来,印度阿育吠陀药典(单篇专论)第一部分,第一卷,于 1989 年出版,随后其他卷在不同年份出版。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验